Scarica l'app Stockscreener
11.33
5.58%
-0.67
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ATRA Giù?
Forum
Previsione
Atara Biotherapeutics Inc Borsa (ATRA) Ultime notizie
Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Receives Average Rating of "Hold" from Brokerages - MarketBeat
How the (ATRA) price action is used to our Advantage - Stock Traders Daily
EcoR1 Capital, LLC Increases Stake in Atara Biotherapeutics Inc - GuruFocus.com
Atara Biotherapeutics Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Atara Biotherapeutics Reports Q3 2024 Financial Progress - TipRanks
Atara Biotherapeutics to Participate at the Stifel 2024 Healthcare Conference - Business Wire
Atara Biotherapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Atara Biotherapeutics (NASDAQ:ATRA) Price Target Raised to $21.00 - MarketBeat
Atara Biotherapeutics: Q3 Earnings Snapshot - Houston Chronicle
Atara Biotherapeutics (ATRA) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Earnings Flash (ATRA) ATARA BIOTHERAPEUTICS Reports Q3 Revenue $40.2M - Marketscreener.com
Atara Biotherapeutics Announces Third Quarter 2024 Financial Results and Operational Progress - Business Wire
(ATRA) On The My Stocks Page - Stock Traders Daily
Atara Biotherapeutics (ATRA) to Release Quarterly Earnings on Tuesday - MarketBeat
Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Surges 34% Yet Its Low P/S Is No Reason For Excitement - Simply Wall St
Atara Biotherapeutics to Announce Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 - Business Wire
Vanguard Group Inc's Strategic Acquisition in Atara Biotherapeutics Inc - GuruFocus.com
Net Present Value Model: Atara Biotherapeutics Inc’s ATA-3219 - GlobalData
Hemophagocytic Lymphohistiocytosis Market to Reach New Heights in Growth by 2034, DelveInsight Predict | Incyte, Novartis, Atara Biotherapeutics, Bellicum Pharma - The Globe and Mail
(ATRA) Trading Signals - Stock Traders Daily
Atara Biotherapeutics names new COO By Investing.com - Investing.com Australia
Atara Biotherapeutics names new COO - Investing.com
Atara Biotherapeutics, Inc. Appoints Eric Hyllengren as Chief Operating Officer - Marketscreener.com
Atara Biotherapeutics (ATRA) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
How to Take Advantage of moves in (ATRA) - Stock Traders Daily
Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
After scoring a first for an off-the-shelf T cell therapy, can Atara maintain momentum? - Yahoo Finance
Pancreatic Cancer Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Dragonfly Therapeutics, Keymed B, Tango Therapeutics, Atara Biotherapeutics, Keymed Biosciences Co. Ltd - Barchart
Trading (ATRA) With Integrated Risk Controls - Stock Traders Daily
How To Trade (ATRA) - Stock Traders Daily
Atara Therapeutics appoints Cokey Nguyen as chief executive - The Pharma Letter
Atara Biotherapeutics Sees Its Stock Price Rise - Los Angeles Business Journal
Atara Biotherapeutics (ATRA) Stock Is Up 20%: What's Going On? - MSN
Atara Biotherapeutics Inc [ATRA] President and CEO makes an insider purchase of 3,038 shares worth 20139.0. - Knox Daily
Atara Biotherapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
Atara Biotherapeutics (ATRA) Secures Strategic Investments to Advance T-cell Immunotherapy Innovations - BP Journal
Atara Biotherapeutics secures $36 million in stock sale - Investing.com
Atara Biotherapeutics Shares Climb on $36 Million Direct Offering - MarketWatch
Atara Biotherapeutics Announces Board Appointment and Capital Raise - TipRanks
Atara Biotherapeutics Announces $36 Million Registered Direct Offering - StockTitan
Atara Biotherapeutics Inc’s latest rating changes from various analysts - Knox Daily
(ATRA) Proactive Strategies - Stock Traders Daily
Atara Biotherapeutics EVP sells over $7k in company stock - Investing.com India
Atara biotherapeutics EVP sells shares worth over $6,300 - Investing.com India
Atara Biotherapeutics EVP sells over $7k in company stock By Investing.com - Investing.com South Africa
Atara biotherapeutics EVP sells shares worth over $6,300 By Investing.com - Investing.com South Africa
Atara Biotherapeutics EVP sells shares worth over $7,600 - Investing.com India
Atara Biotherapeutics CEO sells over $20k in company stock - Investing.com
Atara biotherapeutics EVP sells shares worth over $12,000 - Investing.com
Atara Biotherapeutics EVP sells shares worth over $7,600 By Investing.com - Investing.com Canada
Atara biotherapeutics EVP sells shares worth over $12,000 By Investing.com - Investing.com UK
Alzamend Neuro (ALZN) Could Triple from current levels and here’w why - BP Journal
3.66%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):